Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.965
-0.165 (-5.27%)
At close: Feb 21, 2025, 4:00 PM
2.970
+0.005 (0.17%)
After-hours: Feb 21, 2025, 5:28 PM EST
Prime Medicine Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$13.13
Upside
+342.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Initiates $10 | Buy | Initiates | $10 | +237.27% | Dec 10, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +507.08% | Dec 3, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +405.90% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +237.27% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +237.27% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +237.27% | Oct 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +237.27% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +237.27% | May 20, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +237.27% | May 16, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +405.90% | May 13, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $23 → $15 | Strong Buy | Initiates | $23 → $15 | +405.90% | May 7, 2024 |
| Wedbush | Wedbush | Buy Reiterates $12 | Buy | Reiterates | $12 | +304.72% | Apr 23, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +473.36% | Apr 22, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 8, 2024 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +304.72% | Apr 3, 2024 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +304.72% | Apr 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.